Patent · US Active

Prodrugs of HIV protease inhibitors

US7718633B2 · kind B2 · utility

1Cited by
2References
42Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 29, 2005
Grant dateMay 18, 2010
Priority date—
Expiry dateSep 13, 2027

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A compound of the formulais disclosed as a prodrug of an HIV protease inhibitor. Methods and compositions for inhibiting HIV protease activity and treating HIV infection are also disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.